MIRA INFORM REPORT

 

 

Report Date :

04.07.2013

 

IDENTIFICATION DETAILS

 

Name :

SANJEEVANI BIO-TECH EXIM PRIVATE LIMITED

 

 

Registered Office :

A-216, Tower-A, Siddhi Vinayak Tower, B/H Sarkhej Police Station, Makarba Ahmedabad-382213, Gujarat 

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

09.06.2010

 

 

Com. Reg. No.:

04-061053

 

 

Capital Investment / Paid-up Capital :

Rs. 1.600 millions

 

 

CIN No.:

[Company Identification No.]

U51397GJ2010PTC061053

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Pharmaceutical Products.

 

 

No. of Employees :

25 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (30)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 8000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a moderate track record.

 

The financial strength of the company is below average due to low reserves and low profit margin.

 

However, trade relations are fair. Business is active. Payment terms are slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

SE 3B

Rating Explanation

Moderate financial strength and  moderate performance capability.

Date

28.07.2012

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Abhinav Sandip Bhargava

Designation :

Director

Contact No.:

91-9724300703

Date :

03.07.2013

 

 

LOCATIONS

 

Registered Office :

A-216, Tower-A, Siddhi Vinayak Tower, B/H Sarkhej Police Station, Makarba Ahmedabad-382213, Gujarat, India

Tel. No.:

91-79-29701887

Mobile No.:

91-9724300703 / 9724309703 (Abhinav Sandip Bhargava)

Fax No.:

Not Available

E-Mail :

bhargava@sanjeevanibiotech.com

Website :

www.sanjeevanibiotech.com

Location :

Owned

 

 

Factory :

Located at

 

·         Chhatral, Ahmedabad, Gujarat, India

 

 

DIRECTORS

 

As on 28.09.2012

 

Name :

Mr. Rajiv Bhargav

Designation :

Director

Date of Birth/Age :

17.03.1967

Date of Appointment :

21.12.2011

DIN No.:

03047185

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24239GJ2008PTC054593

HEAL SURE LIFESCIENCES PRIVATE LIMITED

Director

01-04-10

01-04-10

22-08-11

Active

NO

2

U51397GJ2010PTC061053

SANJEEVANI BIO-TECH EXIM PRIVATE LIMITED

Director

21-12-11

21-12-11

-

Active

NO

 

 

Name :

Mr. Abhinav Sandip Bhargava

Designation :

Director

Date of Birth/Age :

13.08.1990

Date of Appointment :

14.10.2011

DIN No.:

03060621

 

 

Name :

Mr. Ranjana Sanjay Bhargav

Designation :

Director

Date of Birth/Age :

14.04.1962

Date of Appointment :

14.10.2011

DIN No.:

03576851

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U51397GJ2010PTC061053

SANJEEVANI BIO-TECH EXIM PRIVATE LIMITED

Director

14-10-11

14-10-11

-

Active

NO

2

U24230GJ2011PTC064483

OMGENE LIFE SCIENCES PRIVATE LIMITED

Director

01-02-12

01-02-12

-

Active

NO

 

 

Name :

Saloni Sandipbhai Bhargava

Designation :

Director

Date of Birth/Age :

06.09.1991

Date of Appointment :

24.10.2011

DIN No.:

05106402

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 28.09.2012

 

Names of Shareholders

 

No. of Shares

Sandip Rajendranath Bhargava

 

45000

Jyoti Sandip Bhargava

 

5000

Sanjay Bhargava

 

15000

Rajiv Bhargava

 

17500

Abhinav Bhargava

 

27500

Saloni Bhargava

 

20000

Ranjana Bhargava

 

30000

Total

 

160000

 

As on 28.09.2012

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Pharmaceutical Products.

 

 

Products :

·         Analgesics

Anti Malaria Drugs

Antibiotics and Antibacterials

Antibiotics And Anti-Bacterial

Ayurvedic Formulation

Ayurvedic Medicine

Azithromycin Tablets

Cefpodoxime Proxetil Tablets

Cest Medicine

Ciprofloxacin tablet

Gastric Related Products

Gastric Tablets

Gynec Medicine

Health Care Nutritionals

Levofloxacin Tablets

Multivitamin with Cyproheptadine Syrup and Caplet

Ofloxacin Cefixime Tablets

Omeprazole Capsules

Respiratory System

Tablets And Syrups

 

 

Exports :

 

Products :

Pharmaceutical Products

Countries :

African Countries

 

 

Terms :

 

Selling :

Cash and Credit (30 days and 60 days)

 

 

Purchasing :

Cash and Credit (30 days and 60 days)

 

 

GENERAL INFORMATION

 

Suppliers :

·         Enora Enterprise

S M Lifecare

Super Crop Safe Limited

Ami Printers

Anhil Caps

Jay Boxes

Keepet Containers

Parikh Sales Agency

Shree Matangi Printers

Vaibhav Packers

 

 

Customers :

Wholesalers, Retailers and End Users

 

·         Dawa Pharma

Jiya Healthcare

Eva Bio Tech

J B Enterprises

Anas Healthcare

Altowba Pharma

Ruchi Enterprises

Sara Pharma

Shree Agencies

Shyam Medical Agency

 

 

No. of Employees :

25 (Approximately)

 

 

Bankers :

·         HDFC Bank Limited, Ambavadi Branch, Ahmedabad, Gujarat, India

 

HDFC Bank Limited, HDFC Bank Housesenapati Bapat Marg, Lower Parel (West), Mumbai-400013, Maharashtra, India

 

·         Corporation Bank, Satellite Branch, Om Towers, Satellite, Next to Star Bazaar, Ahmedabad-380015, Gujarat, India

 

 

Facilities :

Cash Credit : Rs. 7.000 millions (From HDFC Bank Limited)

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

V.K. Jindal and Company

Chartered Accountants

Address :

B-704, Nar Narayan Complex, Near Swastik Cross Roads, Navrangpura, Ahmedabad-380009, Gujarat, India

Tel. No.:

91-79-26407744

Fax No.:

91-78-26407744

E-Mail :

vk_kk@yahoo.co.in

PAN No.:

AABFV2907L

 

 

CAPITAL STRUCTURE

 

As on 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

160000

Equity Shares

Rs.10/- each

Rs. 1.600 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

160000

Equity Shares

Rs.10/- each

Rs. 1.600 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

1.600

0.100

(b) Reserves & Surplus

 

0.538

0.102

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

2.138

0.202

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

2.886

0.107

(b) Deferred tax liabilities (Net)

 

0.019

0.004

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

0.000

0.000

Total Non-current Liabilities (3)

 

2.905

0.111

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

0.000

0.000

(b) Trade payables

 

21.315

4.318

(c) Other current liabilities

 

1.152

0.333

(d) Short-term provisions

 

0.000

0.000

Total Current Liabilities (4)

 

22.467

4.651

 

 

 

 

TOTAL

 

27.510

4.964

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

0.201

0.056

(ii) Intangible Assets

 

0.070

0.000

(iii) Capital work-in-progress

 

0.000

0.000

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

2.208

0.160

(e) Other Non-current assets

 

0.013

0.017

Total Non-Current Assets

 

2.492

0.233

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

16.145

0.207

(c) Trade receivables

 

7.502

3.020

(d) Cash and cash equivalents

 

1.216

1.484

(e) Short-term loans and advances

 

0.000

0.000

(f) Other current assets

 

0.155

0.020

Total Current Assets

 

25.018

4.731

 

 

 

 

TOTAL

 

27.510

4.964

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Local Sales

 

5.622

 

 

Export Sales

 

 

5.235

 

 

Other Income

 

 

0.548

 

 

TOTAL                                    

 

61.244

11.405

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Purchase of Traded Goods

 

10.240

 

 

Direct Expenses

 

 

0.082

 

 

Administrative Expenses

 

 

1.137

 

 

Priliminary Exp. W/off

 

 

0.004

 

 

(Increase)/ Decrease in Stock

 

 

(0.207)

 

 

TOTAL                                    

 

60.376

11.256

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

0.868

0.149

 

 

 

 

 

Less

FINANCIAL EXPENSES                        

 

0.235

0.000

 

 

 

 

 

 

PROFIT BEFORE TAX

 

0.633

0.149

 

 

 

 

 

Less

TAX                                                                 

 

0.182

0.047

 

 

 

 

 

 

PROFIT AFTER TAX

 

0.451

0.102

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

37.500

NA

 

 

 

 

 

 

Earnings zPer Share (Rs.)

 

2.82

10.21

 

Particulars

 

 

 

31.03.2013

 

 

 

 

Sales Turnover (Approximately)

 

 

133.000

 

 

 

 

 

Expected Sales (2013-2014) : Rs. 200.000 millions

 

The above information has been parted by Mr. Abhinav (Director)

 

 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2012

31.03.2011

PAT / Total Income

(%)

 

0.74

0.89

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

 

NA

1.37

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

 

2.30

3.00

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

 

0.30

0.74

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

 

1.35

0.53

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

1.11

1.02

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last two years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

Yes

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

Yes

18]

Major customers

Yes

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

UNSECURED LOANS

 

Particulars

31.03.2012

(Rs. in Millions)

31.03.2011

(Rs. In Millions)

Loan from Directors

 

 

Abhinav Bhargav-Loan

0.027

0.000

Jyoti Bhargav

0.020

0.050

Ranjana Bhargav-Loan

0.300

0.000

Sandip Bhargav-Loan

0.053

0.005

Loan from others

 

 

Anishbhai Patel

0.098

0.000

Dipak Patel

0.020

0.052

Ruhi Singhania

0.200

0.000

Sanjay Bhargava

0.712

0.000

Shree Shivashiv Trading Company

1.456

0.000

Total

2.886

0.107

 

 

BANKERS CHARGES REPORT AS PER REGISTRY

 

Corporate identity number of the company

U51397GJ2010PTC061053

Name of the company

SANJEEVANI BIO-TECH EXIM PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

A-216, Tower-A, Siddhi Vinayak Tower, B/H Sarkhej Police Station, Makarba Ahmedabad-382213, Gujarat, India 

E-mail: bhargava@sanjeevanibiotech.com

This form is for

Modification of charge

Charge identification (ID) number of the charge to be modified

10387837

Type of charge

Immovable property

Book debts

Movable property (not being pledge)

Floating charge

Particular of charge holder

HDFC Bank Limited, HDFC Bank Housesenapati Bapat Marg, Lower Parel (West), Mumbai-400013, Maharashtra, India

E-mail: RBBform8@hdfcbank.com

Nature of instrument creating charge

Memorandum Recording Past Transactions of Creation of Mortgage by Deposit of Title Deeds.

Date of instrument Creating the charge

02.01.2013

Amount secured by the charge

Rs. 7.000 millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

Interest at the rate as may be communicated by the Bank from time to time.

 

Terms of Repayment

On demand.

 

Margin

As may be stipulated by the Bank from time to time.

 

Extent and Operation of the charge

The Company created an equitable mortgage by way of deposit of title deeds in respect of its immovable properties security for the due repayment of Rs.7.000 millions by the Company including principal amount of the Facility, interest, liquidated damages, costs, charges and expenses etc.

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Immovable Property being at Office No. A-216, admeasuring 890 Sq. Ft. along with undivided propertionate share in the land, 2nd floor, Tower- A, Siddhi Vinayak Towers, Survey No. 195/2, 196/1+2/A, 206, 211/1, 211/3, 212/1 and 212/2, draft Final Plot No. 12 to 18, TPS No. 84/B of Mouje, Makarba, Taluka City, District Ahmedabad, Registration Sub District Ahmedabad- 380004 (Paldi).

 

Hypothecation by way of First Charge on Stocks and Book Debts of the Company.

Particulars of the present modification

In addition to the existing securities of Stocks and Book Debts, the charge of Rs.7.000 millions shall also now further secured against the equitable mortgage of immovable property situated at District Ahmedabad- 380004 (Paldi).

 

 

FIXED ASSETS

 

v      Tangible Assets

Computer

Blackberry – 9790

Furniture and Fixture

v      Intangible Assets

Barcode Software

Software “PDISPLUS”


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.10

UK Pound

1

Rs.91.07

Euro

1

Rs.77.95

 

 

INFORMATION DETAILS

 

Information Gathered by :

JML

 

 

Report Prepared by :

MRI

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

30

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.